Article
Impact of GRM7 gene variations on glioblastoma risk in the Iranian population.
Molecular and cellular probes - 1 Dec 2024
Jamali Elena, Harsij Atefeh, Yarahmadi Mohammadamin, Bidari-Zerehpoush Farahnaz, Gholinezhad Yasaman, Eslami Solat, Farahzadi Hossein, Agahi Fariba, Fathi Mohadeseh, Ghafouri-Fard Soudeh, Samadian Mohammad
Abstract excerpt
AIM: The metabotropic glutamate receptor, GRM7 is a gene in the neurotransmitters prognostic signatures. Downregulation of this gene is associated with the progression of glioma tumors and has a negative impact on the immune response. METHODS: In the present study, we aim to assess the associations between rs6782011 and rs779867 SNPs within this gene and risk of glioblastoma multiforme (GBM) in Iranian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
